Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ARDMQ
Aradigm
$0.05
$0.05
$0.02
$0.20
$764KN/A21,923 shsN/A
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
$0.62
+1.7%
$0.82
$3.01
$13.40
$2.51M-0.0822,626 shs201,288 shs
Escalon Medical Corp. stock logo
ESMC
Escalon Medical
$0.35
+12.9%
$0.33
$0.11
$0.46
$2.60M0.354,225 shs2,923 shs
YBGJ
Yubo International Biotech
$0.01
$0.04
$0.01
$0.54
$2.28M3.63251,203 shsN/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ARDMQ
Aradigm
0.00%0.00%0.00%0.00%0.00%
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
+4.52%+7.84%+10.52%-56.02%-94.27%
Escalon Medical Corp. stock logo
ESMC
Escalon Medical
0.00%+16.67%-10.26%+19.78%+207.02%
YBGJ
Yubo International Biotech
0.00%+48.89%-58.83%-82.28%-96.81%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ARDMQ
Aradigm
$0.05
$0.05
$0.02
$0.20
$764KN/A21,923 shsN/A
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
$0.62
+1.7%
$0.82
$3.01
$13.40
$2.51M-0.0822,626 shs201,288 shs
Escalon Medical Corp. stock logo
ESMC
Escalon Medical
$0.35
+12.9%
$0.33
$0.11
$0.46
$2.60M0.354,225 shs2,923 shs
YBGJ
Yubo International Biotech
$0.01
$0.04
$0.01
$0.54
$2.28M3.63251,203 shsN/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ARDMQ
Aradigm
0.00%0.00%0.00%0.00%0.00%
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
+4.52%+7.84%+10.52%-56.02%-94.27%
Escalon Medical Corp. stock logo
ESMC
Escalon Medical
0.00%+16.67%-10.26%+19.78%+207.02%
YBGJ
Yubo International Biotech
0.00%+48.89%-58.83%-82.28%-96.81%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ARDMQ
Aradigm
0.00
N/AN/AN/A
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
0.00
N/AN/AN/A
Escalon Medical Corp. stock logo
ESMC
Escalon Medical
0.00
N/AN/AN/A
YBGJ
Yubo International Biotech
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ARDMQ
Aradigm
N/AN/AN/AN/AN/AN/A
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
N/AN/AN/AN/AN/AN/A
Escalon Medical Corp. stock logo
ESMC
Escalon Medical
$11.98M0.22$0.04 per share9.71N/A
YBGJ
Yubo International Biotech
N/AN/AN/AN/A($0.03) per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ARDMQ
Aradigm
N/AN/A0.00N/AN/AN/AN/AN/A
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
Escalon Medical Corp. stock logo
ESMC
Escalon Medical
-$130K$0.057.00N/A4.70%45.60%12.66%N/A
YBGJ
Yubo International Biotech
-$1.77M-$0.02N/AN/AN/AN/A-113.70%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ARDMQ
Aradigm
N/AN/AN/AN/AN/A
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
N/AN/AN/AN/AN/A
Escalon Medical Corp. stock logo
ESMC
Escalon Medical
N/AN/AN/AN/AN/A
YBGJ
Yubo International Biotech
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ARDMQ
Aradigm
N/AN/AN/A
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
N/AN/AN/A
Escalon Medical Corp. stock logo
ESMC
Escalon Medical
0.14
1.92
1.23
YBGJ
Yubo International Biotech
N/A
0.13
0.12
CompanyEmployeesShares OutstandingFree FloatOptionable
ARDMQ
Aradigm
2315.28 millionN/ANot Optionable
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
N/A4.04 million2.68 millionNot Optionable
Escalon Medical Corp. stock logo
ESMC
Escalon Medical
407.42 million7.27 millionNot Optionable
YBGJ
Yubo International Biotech
20170.42 million53.68 millionNot Optionable

Recent News About These Companies

Yubo International Biotech Limited (OTCMKTS:YBGJ) Short Interest Update
Yubo International Biotech Limited (YBGJ)
Yubo International Biotech Limited
YBGJ Yubo International Biotech Limited
Yubo International Biotech Ltd.
Chemical Engineering (Biotechnology) ME
Biotechnology – A Solution to Hunger?
GLOBAL TOTAL REWARDS AND INTERNATIONAL MOBILITY HEAD
Biology news

Media Sentiment Over Time

Aradigm OTCMKTS:ARDMQ

$0.05 0.00 (0.00%)
As of 06/30/2020

Aradigm Corp. is a leading developer of advanced pulmonary drug delivery systems for the treatment of systemic conditions as well as lung diseases. Their hand-held AERx platform is being designed for the rapid and reproducible delivery of a wide range of pharmaceutical drugs and biotech compounds via the lung.

Bellevue Life Sciences Acquisition stock logo

Bellevue Life Sciences Acquisition NASDAQ:BLAC

$0.62 +0.01 (+1.66%)
As of 09/12/2025

Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.

Escalon Medical stock logo

Escalon Medical OTCMKTS:ESMC

$0.35 +0.04 (+12.90%)
As of 09/12/2025 09:48 AM Eastern

Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea. The company also provides Ispan Intraocular Gases, such as C3F8 and SF6 that are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and AXIS Image management system for managing ophthalmic diagnostic images through the web browser from various devices. In addition, it markets disposable surgical packs used in vitreoretinal surgery, including packs that aid surgeons in the process of injecting and extracting silicone oil. Further, the company engages in the manufacturing and distribution of patented disposable universal gas kit, which delivers the gas from the canister to the patient. It sells its products to medical institutions through independent sales representatives, network of distributors, and internal sales employees. Escalon Medical Corp. was incorporated in 1987 and is headquartered in Wayne, Pennsylvania.

Yubo International Biotech OTCMKTS:YBGJ

$0.01 0.00 (0.00%)
As of 09/12/2025

Yubo International Biotech Limited, through its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is headquartered in Beijing, China.